NCT01585987 An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy Status COMPLETED Phase PHASE2
NCT01585623 Drug Interaction Study of SAR302503 in Patients With Solid Tumor Status COMPLETED Phase PHASE1
NCT01581203 Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) Status COMPLETED Phase PHASE3
NCT01555879 Real-world Clinical Efficacy of Abatacept in the T3 Data Registry Status COMPLETED Phase N/A
NCT01540461 Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC) Status COMPLETED Phase PHASE1
NCT01535677 To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately Status COMPLETED Phase PHASE1
NCT01525823 Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin Status COMPLETED Phase PHASE1
NCT01525810 Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial Status COMPLETED Phase N/A
NCT01525693 Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China Status UNKNOWN Phase N/A
NCT01525212 Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients Status WITHDRAWN Phase PHASE1
NCT01524991 First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT01523171 Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib Status COMPLETED Phase PHASE2
NCT01520350 Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study Status TERMINATED Phase PHASE3
NCT01515189 Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab Status COMPLETED Phase PHASE3